Citadel Advisors’s Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Sell
6,965
-13,033
-65% -$696K ﹤0.01% 10058
2025
Q4
$1.01M Buy
19,998
+12,130
+154% +$621K ﹤0.01% 7372
2025
Q3
$400K Sell
7,868
-40,220
-84% -$1.97M ﹤0.01% 9674
2025
Q2
$2.24M Buy
+48,088
New +$2.09M ﹤0.01% 5491
2025
Q1
Sell
-29,573
Closed -$1.39M 15875
2024
Q4
$1.39M Buy
+29,573
New +$1.42M ﹤0.01% 6382

Other funds holding MSSM

Citadel Advisors's MSSM Position: Q1 2026 in Review

Citadel Advisors reduced its Morgan Stanley Pathway Small-Mid Cap Equity ETF (MSSM) stake by 65% in Q1 2026, selling an estimated $696K and leaving 6,965 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #10058.

Citadel Advisors first reported a position in MSSM in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.24M in Q2 2025. 21 funds tracked by Wall St. Rank hold MSSM as of Q1 2026.

  • Citadel Advisors held 6,965 shares of Morgan Stanley Pathway Small-Mid Cap Equity ETF worth $360K as of Q1 2026.
  • Citadel Advisors sold 13,033 Morgan Stanley Pathway Small-Mid Cap Equity ETF shares in Q1 2026, an estimated $696K.
  • Morgan Stanley Pathway Small-Mid Cap Equity ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10058 holding.
  • Citadel Advisors first reported a position in Morgan Stanley Pathway Small-Mid Cap Equity ETF in Q4 2024 and has held it in 5 quarters since.
  • Citadel Advisors's Morgan Stanley Pathway Small-Mid Cap Equity ETF position peaked at $2.24M in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Morgan Stanley Pathway Small-Mid Cap Equity ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.